After five years of increases likely tied to the COVID-19 pandemic, cardiovascular deaths in the U.S. declined in 2023, according to the American Heart Association’s 2026 Heart Disease and Stroke Statistics update, published Jan. 21 in Circulation. The annual report…
The Latest
Armonk, N.Y.-based White Plains Hospital Physician Associates has launched the WPHPA Hudson Valley Cardiovascular Group in Yorktown Heights, N.Y., bringing together eight cardiologists, according to a Jan. 22 Westfair Business Journal report. The physicians specialize in general and clinical cardiology,…
A bipartisan congressional spending bill unveiled includes multiple cardiology-focused provisions, including extended Medicare telehealth flexibilities and the return of in-home cardiopulmonary rehabilitation services. The appropriations package would fund HHS and the Labor and Education departments through fiscal 2026. Lawmakers are…
Researchers at Rochester, Minn.-based Mayo Clinic have developed an AI model that estimates left ventricular ejection fraction from a single echocardiographic frame. Unlike models that rely on video, the Mayo tool uses deep learning and computer vision to assess cardiac…
Nashville, Tenn.-based Vanderbilt University Medical Center has partnered with Bayer to advance therapeutics for the treatment of cardiovascular and kidney diseases. The collaboration will last five years through an Investigational New Drug application, according to a Jan. 20 news release…
From division chiefs and vice chairs to anesthesiology and catheterization, here are 10 systems seeking cardiology leaders:
As the obesity rate in the U.S. reaches “epidemic proportions,” the rate of hypertension-related cardiovascular death has nearly doubled, according to the American College of Cardiology’s inaugural “Cardiovascular Statistics 2026” report published Jan. 12. Here are 10 things to know…
Bay Shore, N.Y.-based South Shore University Hospital became the first hospital on Long Island to complete a robot-assisted total endoscopic mitral valve repair. The procedure was performed using the DaVinci Xi surgical robot, which enables physicians to conduct the repair…
HHS’ Advanced Research Projects Agency for Health has launched a program to develop AI tools for managing cardiovascular disease. The initiative, called ADVOCATE, aims to create AI agents that assist patients with tasks such as scheduling, lifestyle guidance and prescription…
Stony Brook (N.Y.) Heart Institute became the first center globally to administer a commercial dose of plozasiran, a newly approved RNA-interference therapy for familial chylomicronemia syndrome. The Center for Advanced Lipid Management delivered the therapy within days of FDA approval,…